Clinical Trial Update: Efficacy and Safety of Hetrombopag in Preventing Chemotherapy-induced Thrombocytopenia in Gastrointestinal Tumors [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of hetrombopag to prevent chemotherapy-induced thrombocytopenia in patients with gastrointestinal tu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Thrombocytopenia
• Gastrointestinal Cancer

Drugs mentioned

• Hetrombopag (hetrombopag)

Snippet

Sponsor: Changhai Hospital | Conditions: Chemotherapy-induced Thrombocytopenia (CIT) in Patients With Gastrointestinal Tumors | Phase 2 | Status: RECRUITING